Novartis AG NVS
150.47 USD -0.75 (-0.50%)
Regular-session close
150.00 -0.47 -0.31%
After hours · Nov 20, 7:17 PM ET
150.24 Day range 152.70
124.36 52-week range 168.62
- YTD
- +9.14%
- 1 year
- +21.00%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 56.67B | 51.72B | 46.66B | 43.46B | 43.97B | |
| 42.98B | 38.90B | 34.19B | 31.88B | 32.24B | |
| 17.64B | 14.54B | 9.77B | 7.95B | 10.06B | |
| 13.98B | 11.94B | 14.85B | 6.96B | 24.02B | |
| 7.15 | 5.87 | 7.10 | 3.17 | 10.63 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 11.44B | 11.46B | 13.39B | 7.52B | 12.41B | |
| 110.95B | 102.25B | 99.94B | 117.45B | 131.79B | |
| 64.40B | 58.12B | 53.20B | 58.03B | 63.97B | |
| 35.46B | 31.40B | 26.44B | 27.96B | 31.09B | |
| 46.13B | 44.05B | 46.67B | 59.34B | 67.66B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 19.14B | 17.62B | 14.46B | 14.24B | 15.07B | |
| -4.88B | -7.51B | 5.60B | 1.47B | 4.21B | |
| -14.87B | -11.74B | -14.28B | -20.56B | -16.26B | |
| -1.53B | -1.28B | -823.00M | -758.00M | -855.00M | |
| -24.00M | -1.93B | 5.88B | -4.89B | 2.75B |
